Vitamins represent precursor molecules for the majority of cofactors essential for various enzyme activities. Is the expression of proteins that require a specific cofactor for their function correlated to its availability? Examples are presented and discussed of the involvement of vitamin-derived cofactors in the regulatory mechanisms controlling gene expression in bacteria and eukaryotes at the transcriptional and trans lational level.
Vitamins represent precursor molecules for the majority of the cofactors essential for various enzyme activities. Vitamin deficiency thus leads to an insufficient cofactor supply for biochemical reactions with consequences on cell function. Compared to the enormous amount of data on the effects of vitamin deficiency on physiological and biochemical parameters, little is known about the molecular mechanisms underlying the adaptive response of cells and organisms to variations in cofactor supply. Is the expression of proteins that require a specific cofactor for its function correlated to its availability? There are many examples of changes in the activity of a particular enzyme caused by a suboptimal cofactor supply: a) The most direct effect is the reduced formation of holoenzyme during or following synthesis of the apoenzyme. b) Incorporation of the cofactor stabilizes the conformation of the enzyme polypeptide and reduces its sensitivity to pro teolytic degradation (1); thus, a decreased enzyme activity in vitamin deficiency may reflect the higher rate of proteolytic degradation of the corresponding apoen zyme. c) The reduced level of a particular enzyme protein may be a consequence of a reduced expression of that protein at the transcriptional or translational level. Regulatory mechanisms controlling gene expression at the transcriptional and translational level are well documented in bacteria and eukaryotes in the case of inorganic cofactors. Organisms have evolved adaptive devices to meet the chal lenge of a variable supply of trace elements. Specific regulatory proteins bind to recognition sequences on the mRNA according to the availability of the metal ion (e. g. iron-responsive elements in ferritin and transferrin receptor mRNA) or represent transcription factors that bind to recognition sequences in the promoter region, e. g. of metallothioneine genes in eukaryotes or the mercury-resistance operon in bacteria. These metal-dependent regulatory systems have been recently reviewed for prokaryotes (2) as well as eukaryotes (3) .
Have comparable mechanisms evolved as a response to variations in the vitamin supply? When the cofactor supply is limited, the synthesis of inactive apoenzyme may be wasteful for the cell and regulatory devices may be activated to prevent it. Such mechanisms can be expected to be active in bacterial cells with a metabolism trimmed on efficiency. Do they apply to the eukaryotec cell as well? If variations in the amount of a particular enzyme were the result of transcriptional or translational events in response to cofactor supply, such a response would require a signal reception mechanism able to sense variations in cofactor and/or apoenzyme levels and to transduce the sensed value into an adequate response at the level of gene expression.
Besides apoenzyme synthesis an additional site of regulation by vitamin supply is the synthesis of the receptor and carrier proteins involved in the uptake of these molecules. I will discuss examples where variations in vitamin and cofactor supply have been shown to lead to changes in the levels of a particular mRNA or protein .
Changes in enzyme activity only, without data on changes in the expression levels of a particular enzyme will not be considered.
THIAMINE PYROPHOSPHATE (VITAMIN B1)

Prokaryotes
The bacterium Escherichia coil is capable of synthesizing thiamine de novo. The genes involved in thiamine biosynthesis are spread throughout the E. coil genome. Their regulation has only recently become the subject of a more detailed investigation (4) and data on involvement of the cofactor in the regulation of its biosynthetic genes and expression of its apoenzymes are not yet available.
Eukaryotes
Recently, the regulation by thiamine of genes involved in biosynthesis and transport in yeast has been analyzed in greater detail. Interest in this regulation was initiated by the discovery that one of the two acid phosphatases of yeast cells, encoded by pho3 in Saccharomyces cerevisiae and pho4 in S. pombe, is not repressible by phosphate but by low concentrations of thiamine (5) . This thiamine-repressible acid phosphatase is an N glycosylated cell wall protein involved in dephosphoryla tion of thiamine phosphates present in the growth medium (6, 7) . Northern blot analysis of pho4 mRNA levels revealed that regulation by thiamine is at the transcriptional level (5) .
By screening a genomic library of S. pombe, Maundrell (8) identified and isolated one gene that was highly expressed in cells grown in minimal medium and repressed in medium containing thiamine. This gene, called initially nml, turned out to be identical to the gene thi3 responsible for the biosynthesis of the pyrimidine moiety of the thiamine molecule (7) . Expression of transcripts of this gene was highly sensitive to thiamine as determined by Northern blots at the mRNA level. Thiamine-sensitivity of the expression could be transferred to a thi3 promoterchloramphenicol acetyltransferase (CAT) gene which suggests that the promoter of the thi3 gene contains a thiamine-responsive box. Mutation analysis in S. pombe revealed three genes (tnrl, tnr2, tnr3) acting negatively on the expression of the thiamine-sensitive acid phosphatase and one gene (thil) acting positively on the expression of these genes (9) . Thus, the mutations seem to affect genes encoding regulatory proteins that interact with the promoter of the thiamine-sensitive genes and transduce the effect of the cofactor. There are common sequence motifs within the promoter domains of the acid phosphatase and the thiamine synthetic enzyme nml (thi3) that may represent binding sites for a transcription factor involved in the thiamine-mediated control of these genes (9).
Transport
S. pombe cells apparently possess a very efficient transport system for thiamine since thiamine added to the growth medium is rapidly taken up and accumulated within the cell (10) . When the intracellular concentration of thiamine exceeds a certain level, the transport mechanism is shut down (9) . These observations suggest that thiamine also controls the expression of the gene encoding the transporter protein.
Similar results were obtained with the yeast S. cerevisiae (11) (12) (13) . Two regulatory genes are involved in the expression of the thiamine-sensitive genes. One, THI2 controls expression of the thiamine-sensitive acid phosphatase and the thiamine biosynthetic genes. The second gene, THIS, controls thiamine transport in addition to the phosphatase and the biosynthetic genes also (12) .
Comments
The picture emerging from the studies in the yeasts S. pombe and S. cerevisiae shows that transcription factors respond to the intracellular level of thiamine or thiamine phosphate; by binding to a thiamine-responsive box in the promoter of target genes, they regulate positively or negatively the expression of these genes. The target genes are those involved in thiamine metabolism including biosynthesis, degradation, and transport (Fig. 1) . Thus, in yeast the availability of the cofactor autoregulates its own synthesis.
FLAVINS (VITAMIN B2) Prokaryotes
Riboflavin-derived FMN and FAD are the versatile redox cofactors of a large number of flavoenzymes. The biosynthesis of riboflavin was studied extensively in Bacillus subtilis (for a review see (14) ) and it was recognized early during these studies that riboflavin synthase is subject to regulation by riboflavin-dependent feedback (15) (16) (17) . Recently, an analysis of the regulatory region of the riboflavin operon of B. subtilis was presented by Kul et al. (18) . Expression of the operon is regulated by the ribC gene product. It represents a repressor that binds riboflavin, FMN, or FAD as corepressors. This system illustrates the direct interaction between a regulatory protein and flavin cofactors. An example of a flavoenzyme with both enzyme activity and repressor function is provided by the regulation of proline utilization in E. coli and Salmonella typhimurium (19) (20) (21) . These bacteria are able to use proline as carbon and nitrogen sources. Two genes represent the put operon. One gene, putP, encodes the proline permease and the second gene, putA, encodes a multifunctional protein that catalyzes the degradation of proline to glutamate. The PutA protein exhibits proline oxidase activity and pyrroline-5-carboxylate dehydrogenase activity (22) . The FADH2 generated in the proline oxidation reaction is reoxidized by the electron transport chain of the membrane. The PutA protein must become membrane-associated in order to continue the catalytic cycle. Expression of the put operon is induced by proline; full expression requires in addition cyclic AMP and its receptor protein. Mutations in putA indicated that the PutA protein is also involved in this regulation (23, 24) . It was demonstrated that the PutA protein binds in vitro to multiple sites in the put control region (25) . Based on these results, a model was proposed to explain the participation of the PutA protein in the regulation of proline catabolism (Fig. 2) . When proline is present, the PutA protein becomes associated with the membrane and the put operon is fully ex pressed. In the absence of proline, the PutA protein remains in the cytoplasm and binds to the control region of the operon repressing its induction. Ostrovsky de Spicer and Maloy (26) showed recently that the binding of PutA protein to the put control region is prevented in the presence of proline and an electron acceptor or when PutA is reduced by dithionite. Thus, expression of the put operon is regulated by changes in the redox state of the PutA protein. A riboflavin-dependentJ expression of genes not involved in the biosynthesis of the cofactor was described for the nicotine-degrading enzymes of Arthrobacter oxidans (27) . Expression in this soil bacterium of the nicotine-degrading flavoenzymes is inducible by nicotine (28) . In a riboflavin-requiring mutant, induction by nicotine is riboflavin-dependent. Northern blots revealed that expression of the genes of the nic operon was a function of the riboflavin concentration. Apparently the intracellular FAD concen tration co-regulates at the transcriptional level the expression of the nic genes (29) .
Eukaryotes
A correlation between an increased expression of a flavoenzyme and a cor respondingly increased demaned for riboflavin synthesis was revealed in the lower eukaryote Hansenula polymorpha (30) . When this yeast is grown on methanol, the flavoenzyme alcohol oxidase is synthesized at very high levels. This high level of alcohol oxidase synthesis is correlated with a similarly increased level of riboflavin biosynthetic enzymes (30) . When glucose is added to methanol-grown cells, there is a corresponding decrease in the specific activities of alcohol oxidase and of riboflavin synthetase, riboflavin kinase, and FMN adenylyltransferase (30) . Re pression of the riboflavin-generating enzymes was caused by the increase in concen tration of free FAD in the cell which results from catabolite inactivation of alcohol oxidase and the release of FAD from the enzyme. The same repression of the riboflavin biosynthetic enzymes can be induced by increased levels of extracellular FAD. Thus, synthesis of FAD is feedback-controlled by the level of free FAD which in turn is a function of the intracellular demand of flavoenzymes for the cofactor.
Riboflavin deficiency affects flavoenzyme-containing metabolic pathways dif ferentially (for a recent review see (31) 
Prokaryotes
In bacteria, the analysis of the structure and regulation of the B6 biosynthetic operon is still under investigation (42) and it has not been established yet whether pyridoxal 5'-phosphate or biosynthetic intermediates are involved in the expression of its genes.
Eukaryotes
In mammals, vitamin B6 is required for normal growth, development, nervous system function, functions of the immune system and for the enzymatic activity of over 100 enzymes (43) (44) (45) . The biologically inactive dietary forms, pyridoxal, pyridoxine, and pyridoxamine, are phosphorylated in the liver. An FMNdependent oxidase transforms the phosphorylated pyridoxine to pyridoxal 5'-phosphate, the biochemically active form of the vitamin. Thus, the metabolism of flavins and pyridoxine 5'-phosphate are interconnected (38) . One hint as to how variations in the level of synthesis of B6-dependent enzymes may be regulated by the cofactors is the observation that induction of the hepatic tyrosine aminotransferase by glucocorticoids is inversely correlated to the intracellular concentration of pyridoxal phosphate (46) (47) (48) . During recent years, several cDNA and genomic clones encoding pyridoxal phosphate enzymes have been isolated and characterized (for a review see (49) ) which will lead to a better understanding of how pyridoxal phosphate is involved in their expression.
It has been known for some time that pyridoxal phosphate prevents binding of the hepatic glucocorticoid receptor to DNA-cellulose or ATP-sepharose (46) . More recent work substantiated the assumption that vitamin B6 may play an important role in the modulation of steroid hormone action (for a review see (50) ). Steroid hormone receptors upon interaction in vitro with pyridoxal phosphate are altered in their molecular conformation, surface charge, susceptibility to exogenous proteolysis, DNA binding capacity and intracellular distribution. These interac tions seem to be specific, suggesting a direct interaction between pyridoxal phos phate and the steroid receptor. Algood et al. (51) demonstrated that expression of the CAT gene under the transcriptional control of the glucocorticoid-responsive promoter of the mouse mammary tumor virus depends in HeLa cells on the intracellular pyridoxal phosphate concentration.
When cells were grown in medium supplemented with pyridoxine as a precursor of pyridoxal phosphate, expression of the CAT gene was decreased. Cells kept under conditions of mild vitamin deficiency showed an increase in glucocorticoid-induced activity (Fig. 3) . Thus, pyridoxal phosphate apparently represses the activity of the steroid receptor. It was also reported that, in the nuclei of HTC cells, pyridoxal phosphate binds specifically to a nuclear protein (52) and that it affects transcriptional activation of multiple members of the steroid hormone receptor superfamily in a variety of cells (53) . Thus, vitamin B6 seems to represent a physiological modulator of steroid hormone action involved in the expression of steroid-regulated genes.
Transport
Uptake of the pyridoxal 5'-phosphate precursors by the intestinal cells and the hepatocyte is mediated by receptor/carrier proteins (38) . Recently, it was shown (54) that uptake of vitamin B6 by rat kidney proximal tubular cells is a carrier facilitated, Natdependent process. The regulation of expression of these receptor and carrier proteins at the molecular level has still to be elucidated.
Comments
Variations in the synthesis of particular enzyme proteins correlated with the supply of the vitamin have been documented in mammals. Details of the mecha nisms responsible for this regulation have yet to be worked out, but the most conspicuous characteristic of vitamin B6 related to gene regulation is its repression of the activity of the steroid hormone receptor. The interaction of vitamin B6, or its derived cofactor, with the signal transduction pathway of steroid hormones may explain the variety of physiological effects attributed to variations in the vitamin B6 supply.
COBALAMINS (VITAMIN B12) Prokaryotes
Under anaerobic conditions E. coli and S. typhimurium synthesize vitamin B12 (B12) de novo. Its biosynthesis requires about 30 enzymes; transcription of the cobalamin (cob) operon results in an approximately 20,000-nucleotide-long tran script (55) . Besides anaerobiosis and CAMP, cobalamin itself represses the tran scription of a cob-lacZ fusion (56, 57) . Repression is mediated only by 5-deoxyadenosin-cobalamin but not by other derivatives of cobalamin. Analysis of deletion mutants in the promoter domain of the cob-operon indicated that sequence down stream of the transcriptional start site were reauired for B12 repression (55, 58) . Richter-Dahlfors and Andersson (59) have shown that repression by B12 is linked to sequence elements in the untranslated part as well as to sequences within the coding part of the mRNA. In a cob-lacZ transcriptional fusion, a 618-bp region including leader and coding sequences was required for normal repression. The leader sequence of the cob transcript exhibits sequences that may form hairpin-loops in the mRNA molecule. Point mutations leading to loss of repression by B12 are located within these loops. Methionine synthesis in E. coli and S. typhimurium is subject to complex regulation. The final reaction in the pathway is the transfer of a methyl group to homocysteine (for a review see (60)). Methylation of homocysteine can be performed by two transmethylases (61, 62) . The metE gene product is a B12-independent enzyme and the metes gene product is a B12-dependent transmethylase.
Expression of the metE gene is negatively and positively regulated. It is negatively controlled by the metJ gene product with S-adenosylmethionine (AdoMet) acting as a corepressor (61) (62) (63) (64) . The metE gene is also repressed by the addition of B12 to the growth medium (65) . Repression by B12 requires, besides the metJ gene product, the MetH-B12 holoenzyme. Metes-holoenzyme is formed by the transfer of a methyl group from 5-methyltetrahydrofolate to cobalamin with the formation of methyl-B12. This reaction is catalyzed by the metF gene product; repression by B12 of metE expression depends on a functional metF gene (66) . metE and metF, are positively regualted by the metR gene product (67), a leucine-zippercontaining DNA-binding protein (68) . The metR gene product requires for activity homocysteine, the immediate precursor in methionine synthesis. Wu et al. (69) showed that a large part of the B12-repression of metE is the result of the transformation of homocysteine into methionine by the methyl-B12-containing MetH holoenzyme. The lack of homocysteine required for MetR activation would be the reason for the observed repression of metE by B12 in the growth medium.
Eukaryotes
In mammalian cells, essentially all of the cobalamin is bound to the two B12-dependent enzymes, methionine synthase and methylmalonyl-CoA mutase (70, 71) . The amount of cobalamin is less than the amount of enzyme protein present in these cells; consequently 80-95% of the methylmalonyl-CoA mutase molecules are in the apo-form. The same situation seems to apply to methionine synthase (72) . The addition of adenosine-B12 to purified apomutase or to crude tissue extracts markedly stimulates enzyme activity due to the formation of holomutase. Similar results were obtained with methionine synthase (73) . Apparently, expres sion of the two mammalian B12-dependent enzyme proteins is independent of the supply of the vitamin.
Transport
Under aerobic conditions, enteric bacteria do not synthesize vitamin B12 but take it up by a special transport system. In E. coil, the membrane protein BtuB binds cobalamins with high affinity and, in cooperation with the tonB gene product, Vol. 40, No. 5, 1994 catalyzes the active transport of the vitamin across the cell membrane (74 , 75) . The syntheses of these outer membrane transport proteins are regulated by the availabil ity of their substrates. When grown in the presence of cobalamin, the amount of BtuB protein in the membrane is diminished (76) independent of the expression of the btuB gene from a single or from a multicopy plasmid (77, 78) . This could indicate the prsence of a large excess of hypothetical repressor molecules within the cell, but the search for mutations in a putative repressor gene were unsuccessful . The coding sequence of the btuB transcript is preceded by a 240-nucleotide 5'-leader sequence. Lundrigan et al. (79) showed by the use of a btuB-lacZ gene fusion that mutations within the leader but also sequences within the coding domain of the btuB gene affect expression of the fusion protein. The BtuB protein itself did not autoregulate its own synthesis. The btuB leader sequence and the beginning of the coding sequence exhibit segments of dyad symmetry with the possibility to form alternative secondary structures in the RNA transcript. The ribosomal binding site may be sequestered within these secondary structures . The authors propose a model for the btuB regulation in which secondary structures of the transcript modulate, in a process alalogous to transcriptional attenuation , transcription and translation of the gene.
The regulation of the btuB gene shows similarities to that of the cob operon. In both systems, sequences within the untranslated leader and the coding part of the structural genes are involved in repression control. By comparing the potential hairpin-loop structures of the cob and the btuB mRNAs, a conserved sequence element was identified that was designated the B12 box. This sequence element is located in the leader of the respective mRNAs and shows a high degree of homology. The B12 box may represent an operator site for a regulatory protein that , by interaction with B12, controls the expression of these genes (Fig . 4) .
Uptake of vitamin B12 in mammals has been extensively studied (80) . The precess is complex and involves several B12-binding proteins (80) (81) (82) (83) . Expression of these B12-binding proteins as a function of the availability of the cofactor has, however, not been studied yet in detail at the molecular level.
Comments
Unlike the previously discussed mechanisms, adenosyl-cobalamin does not act as a corepressor of the cobalamin biosynthetic genes in E. coli and S. typhimurium at the transcriptional but at the translational level; it involves sequences situated in the untranslated leader as well as in the coding part of the corresponding mRNA molecule. Interestingly, the regulation of the cobalamin transporter by cobalamin also occurs at the translational level. The regulatory sequences in the mRNA responsible for the cobalamin effect could be defined as the B12 box. Regulation of these two genes by B12 is reminiscent of the regulation of heme-dependent gene expression by iron-rsponsive elements (IRE). The best analyzed IRE are found in the 5'-untranslated region of ferritin mRNA and the 3'-untranslated region of transferrin receptor mRNA (for a review see (84, 85) ). Attachement of the IRE-binding protein (IRE-BP) to the IRE prevents translation of ferritin mRNA and stabilizes transferrin receptor mRNA. It was shown recently that the IRE-BP is identical with aconitase (86) . Aconitase contains an 4Fe-4S cluster in its active centre. When the intracellular iron concentration is low, the Fe-S cluster can not be correctly assembled and this aconitase form exhibits RNA-binding activity. With the Fe-S cluster assembled, the protein exhibits aconitase activity. The nature of a hypothetical B12 box-binding regulatory protein involved in the regulation of the cob operon and btuB has yet to be determined. It will be of interest to find out whether a B12 box can be demonstrated in B12-dependent proteins, e. g. transport proteins, in mammals.
FOLATE COFACTORS (FOLIC ACID)
Tetrahydrofolate and its derivatives 5,10-methylenetetrahydrofolate, 5,10-methenyltetrahydrofolate, 10-formyltetrahydrofolate, 5-formyltetrahydrofolate, and 5-methyltetrahydrofolate are the biologically active forms of folic acid. They are specialized cosubstrates for a variety of enzymes involved in one-carbon transfer reactions important in amino acid and nucleotide metabolism.
Prokaryotes
In E. coli and S. typhimurium, serine hydroxymethyl transferase is a key enzyme in C 1 metabolism. The reaction catalyzed by this enzyme requires THE and is the major source of glycine and C1 units for biosyntheses and methylation reactions in these bacteria (87) . Procucts of C1 metabolism including folate repress the synthesis of the enzyme, but the mechanism of inhibition is not well understood.
Eukaryotes
An example of transcriptional regulation by folate is the expression of the discoidin genes of Dictyostelium (88) . These genes are induced in bacteria-grown cells before the onset of development. The expression of the discoidin genes is repressed in the presence of 1 mM folate or cAMP in the growth medium . With the aid of a DNA fusion between a 411-bp discoidin promoter fragment and the CAT indicator gene, Blusch et al. (88) demonstrated that folate represses transcription of the indicator gene from the discoidin promoter. Different sequence elements within the discoidin promoter were responsible for repression by CAMP and folate , respectively. Folate may be important in the development of Dictyostelium cells as a singal molecule for the presence of bacteria on which this organism feeds (89) .
Dihydrofolate reductase (DHFR) catalyzes the reduction of folate to dihydro folate and then to tetrahydrofolate. DHFR is absolutely essential for the supply of reduced folate cofactors in the de novo synthesis of thymidylate , purines, and glycine. Thus, it is required for growth and expressed in all cells. The antifolate agent, methotrexate, is an analog of dihydrofolate that binds specifically to DHFR and inhibits its enzyme activity. Treatment of cells with methotrexate results in elevated levels of DHFR (90, 91) that are paralleled by an incrase in DHFR mRNA (92) . The 5'-flanking region of the human (93), murine (94) , and hamster (9 5) DHFR genes exhibit a high degree of sequence conservation . Expression from a DHFR promoter-CA T gene transfected into chinese hamster ovary cells increases upon treatment of the cells with methotrexate (92) . Stimulation of the promoter activity by methotrexate is prevented by 5-methyltetrahydrofolate , hypoxanthine, or thymidine, metabolites required in the bioxynthetic pathways of DNA replica tion. This transcriptional behavior of the DHFR promoter suggests a mechanism of inhibition of gene expression in which folate cofactors participate . The structure of the promoter for DHFR with multiple Sp 1 binding sites and the lack of TATAA and CAT motifs shows similarities to the promoters of thymidylate synthetase (96) and ribonucleotide reductase (97) . Folate cofactors may be involved in the regulation of these housekeeping genes as well (92) .
Thymidylate synthase (TS) plays an essential role in DNA synthesis and is therefore an important target enzyme in cancer chemotherapy . It provides the de novo source of deoxythymidine monophosphate from deoxyuridine monophosphate and 5,10-methylenetetrahydrofolate. The cDNA of human (98) and mouse (99) TS have been isolated and sequenced. The expression of the TS gene is regulated with highest activity levels during the period of DNA synthesis . Besides the regulation at the transcriptional level, Chu et al . (100) provided evidence that expression of TS is autoregulated at the mRNA level and that the folate cofactor of TS is involved in this regulation. Gel retardation assays revealed that the TS apoprotein binds specifically to its mRNA and prevents its translation . Binding, and thus inhibition of translation, was relieved by the addition of 5 , 10-methylenetetrahydrofolate or deoxyuridine monophosphate (dUMP) , the substrate of the enzyme, to the in vitro translation assays. The initial 188nt of the TS transcript bind apo-TS with the same affinity as does the complete mRNA (101) . This sequence contains the untranslated leader of the mRNA as well as the AUG start codon. Deletion of the AUG codon and three upstream nucleotides completely abolished TS binding. By comparing the TS binding efficiency to the sense and the antisense sequences, it appears that the loop structure made by the sequence GCCAUG mediates the protein-RNA interaction (Fig. 5) . A second binding site was identified within the coding region of the mRNA corresponding to nucleotides 434-634. A similar prediction was made for the E. coli thymidylate synthase on the basis of the nucleotide sequence of the gene. Belfort et al. (102) suggested that the close proximity of the loop site to the AUG translational start codon might reduce ribosomal binding and thus inhibit translation. Similar observations to those for TS were recently described by Chu et al. (103) for the translational regulation of DHFR-mRNA in vitro. The significance of this autoregulation for the in vivo expression of TS and DHFR has yet to be established.
Transport
In mammalian cells two basic mechanisms of folate uptake have been iden tified. The primary route of folic acid influx is by a carrier-mediated, anion insensitive, low-affinity/high-capacity transport system (104). The major route for the uptake of reduced folate cofactors and the antifolate drug methotrexate is also carrier-mediated (105) . Reduced folate and methotrexate can be taken up also by membrane-associated folate-binding proteins (for a recent review see (106) ).
When grown in the presence of low concentrations of 5-methyltetrahydrofolic acid, certain tissue culture cells express the high affinity membrane receptor for reduced folates (107, 108) . The membrane receptor delivers 5-methyltetrahydro folic acid into a vacuolar compartment and from this compartment the vitamin is transported into the cytoplasm by a specific carrier system (109, 110) . In folate depleted cells, the reduced folate is rapidly delivered to the cytoplasm. Accumula tion in the cytoplasm is inhibited when the cells become replete with folate, suggesting that the transmembrane transport step is regulated by the cytoplasmic concentration of folate. After 4-b h of incubation of tissue cultures in the presence of 5-methyltetrahydrofolate, the uptake of the vitamin levels off (110) . This is correlated with a decrease in the number of receptor molecules (108, 111, 112) . It appears that the expression of folate-binding proteins is regulated by the supply of the vitamin and the intracellular concentration of the cofactor forms. Since a series of cDNAs and genes encoding folate-binding proteins have been isolated (106, 113) , new insights into the regulation of expression of folate-binding proteins at the transcriptional and translational levels will be gained.
Comments
Transcriptional control by folate has been demonstrated in Dictyostelium for the discoidin genes involved in the development of the slime mold. This seems to be a rather special case of adaptation of the developmental cycle of this organism to the presence of nutritional resources in its environment. More importantly, transcriptional control of gene expression by folate cofactors appears to operate in higher organisms. The recent findings of autoregulatory translational control of TS and DHFR mRNA expression are especially significant. Sequences in the un translated leader of the mRNA but also sequences within the coding part of the mRNA are involved in this control. Analysis of the 5'-untranslated and translated sequences of an increasing number of isolated cDNAs allows the prediction of stem-loop structures in the derived mRNAs that may serve as recognition sequences for regulatory proteins. It may be expected that additional examples of trans lational regulation are found and that cofactor levels are involved in this regulation.
BIOTINYL-LYSINE (BIOTIN)
Biotin is covalently attached to a specific lysine residue in all enzymes with biotin as the prosthetic group. Biotin protein ligase, the enzyme catalyzing this reaction, has been isolated and characterized from various sources and is shown to have a broad substrate specificity (114, 115) .
Prokaryotes
In E. coli and other enteric bacteria biotin is synthesized by enzymes encoded in the bio operon. Transcription of this operon is regulated by the protein BirA (116, 117) . Besides its function as a regulatory protein, BirA represents also the biotin-holoenzyme synthetase (biotin-protein ligase). E. coli contains only one biotinylated enzyme, the biotin carboxyl carrier protein of acetyl-CoA carboxylase. The biotinylation of apo-acetyl-CoA carboxylase proceeds in two steps. First, a biotinyl-AMP intermediate is formed. In the presence of apo-carboxyl carrier protein, biotin is transferred in the second step of the reaction to the apo-protein and enzymatically active acetyl-CoA carboxylase is formed (114) . It turned out that the corepressor of BirA (holoenzyme synthase of biotin carboxylases) is biotinyl-AMP, the intermediate formed in the ligase reaction (for a recent review see (118)). Expression of the bio-operon genes becomes repressed when the intracellular biotin level is in excess of the apo-biotin carboxyl carrier protein.
When the supply of apo-biotin carboxyl carrier protein decreases, biotin-AMP remains bound to the ligase. The biotinyl-AMP-ligase complex binds to the operator DNA of the biotin operon and represses transcription (119) . Thus, the enzyme that catalyzes the posttranslational modification of the carboxyl carrier protein is also the repressor of the biotin operon and biotinyl-AMP is the core pressor (Fig. 6 ). This regulatory system is able to subtly adjust the need for cofactor synthesis to the rate of apoenzyme synthesis.
Eukatyotes
In eukaryotic cells, there are at least four biotin enzymes. Pyruvate carboxy lase, propionyl-CoA carboxylase, and methylcrotonyl-CoA carboxylase are mito chondrial enzymes. Acetyl-CoA carboxylase is found in the cytoplasm and the mitochondria (120) . The biotinylating enzyme is found in both the cytoplasm and the mitochondria (120) . The role, if any, played by biotin in the expression of these enzymes has not been elucidated.
There are, however, examples in eukaryotic cells of the participation of biotin in the regulation of the level of certain proteins that do not directly interact with the vitamin. Biotin was shown to modulate at the translational level the expression of glucokinase in cultured rat hepatocytes (121) and of the asialoglycoprotein recep tor in HepG2 cells (122) . In rat hepatocytes, biotin at 10-6M increases the intracellular level of cGMP which seems to mediate the increase in glucokinase activity. In a cell-free translation assay, the effect of biotin and cGMP consists of deamido-NAD and NAD by the gene products NadD and NadE. Analysis of mutants defective in NMN transport allowed to define a genetic locus encoding the bifunctional protein NadI (137) or NadR (138, 139) . It regulates expression of the NAD biosynthetic genes as well as the transport protein encoded by the pnuC gene. The activity of this bifunctional protein seems to be regulated by the intracellular NAD concentration.
Eukaryotes
The direct involvement of NAD or NADP in the regulation of gene expression in eukaryotic cells and higher organisms has still to be demonstrated.
Transport
Transport of NMN and NAD is accomplished by an organic cation carrier (140) (141) (142) . The involvement of the pyridine cofactors in the regulation of expres sion of this carrier protein has not been established.
Comments
The NadI/NadR protein apparently represents a sensor for the intracellular NAD concentration. At high NAD concentrations, it represses the expression of the NAD biosynthetic genes. At the same time, it also interacts with the transport er protein and alters its function so as to inactivate NMN transport. In this system, expression of the enzymes of NAD bioxynthesis and of the transport protein for the NAD precursor, NMN, is coordinately regulated by the same repressor protein in dependence on the intracellular availability of the coenzyme.
CONCLUSION
The data presented in this article reveal several instances of direct interaction between vitamin-derived cofactors and transcription factors. FAD and FMN interact as corepressors with a regulator protein that specifically binds to the operator site of the riboflavin biosynthetic operon in Bacillus subtilis. In E. coil, the NadR protein senses the intracellular NAD level and regulates expression of NAD biosynthetic genes and expression of the NAD transport system accordingly. Fatty acid degradation in enterobacteria is regulated by the interplay between FadR, a repressor protein, and long-chain acylCoA acting as a coreprescor. Folate regulates transcription of the discoidin genes in the slime mold Dictyostelium; thiamine regulates the transcription of its biosynthetic and transport genes in yeast. The intracellular cofactor forms of these vitamins are most probably active in the transcriptional regulation exerted by folate and thiamine. Methyl-cobalamin apparently is involved in the transcriptional regulation of methionine synthase. It is not established how cofactors and regulatory proteins interact.
Most flavoenzymes and NAD(P)-dependent enzymes bind the cofactor by a dinucleotide-binding fold characteristic for these proteins. The various interactions between vitamin supply, cofactor levels and expres sion of dependent enzymes and transport proteins is summarized in Fig. 7 . Following uptake, the vitamin is transformed within the cell into the corresponding cofactor(s). Formation of the cofactor may take place in the cytoplasm or, in the case of the eukaryotic cell, in a cell compartment like the mitochondria. The cofactor level may be sensed in two ways. There may be a direct interaction between the cofactor and a transcription factor or an mRNA-binding protein. In this case, the sensor is the nucleic acid-binding protein. Alternatively, the apoen zyme may be the sensor and exhibit DNA-or RNA-binding activity. In both cases, the expression of the enzyme or carrier encoding gene is regulated by the cofactor supply.
There will be more indirect ways of influencing gene expression in vitamins and thus, cofactor deficiency by variations of enzyme activities essential for biosynthetic reactions. This may be accomplished by the interaction of cofactors with proteins involved in the formation of the transcription complex. Also, gene expression may be modulated by the enzymatic activation or deactivation of regulatory factors, like steroid hormones by, e. g. flavoenzymes. It is clear that a deficiency of energy-producing reactions will eventually lead to the breakdown of the cellular regulatory circuits including gene expression. From the examples presented here, it becomes clear that there are many levels of specific interaction between cofactors and the expression of proteins with which they interact in the cell. It may be expected that many more examples will become available in the near future.
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